Lindsay M. Borgeson

Since joining Kirkland, Lindsay has been involved in the following matters:

• Waud Capital in its acquisition of Senior Helpers from Advocate Aurora
• Rite Aid Corporation (“Rite Aid”) and 119 of its affiliates in their prearranged Chapter 11 cases in the U.S. Bankruptcy Court for the District of New Jersey
• GTCR-backed RevSpring, a provider of communication and payment solutions, in its sale to Frazier Healthcare Partners
• MultiPlan Corp. (NYSE: MPLN) in its $160 million acquisition of Benefits Science, a data and advanced analytics company
• TA Associates in its investment in Intelerad
• One Equity Partners in its acquisition of InfuCare
• Novo Holdings in its acquisition of Medical Knowledge Group LLC
• Owens & Minor in its $1.6 billion acquisition of Apria, Inc.
• TPG in its sale of Medical Solutions, LLC
• Gryphon Investors in its acquisition of Metagenics
• Ares in its acquisition of LaserAway
• Envista in its asset acquisition of Carestream Dental’s dental scanning business 
• Thoma Bravo on its strategic growth investment in Greenphire from The Riverside Company 
• BC Partners in its acquisition of Women’s Care Enterprises
• Nordic Capital in its acquisition of United Veterinary Care
• Thomas H. Lee Partners in its management of Nextech
• Bain Capital in its management of HST Pathways
• HST Pathways in its acquisition of Clariti Health
• Waud Capital in its acquisition of iPass
• The Susan G. Komen Foundation providing ongoing healthcare privacy counsel related to the implementation of programming initiatives (including research efforts, patient navigator programs, and programs designed to increase patient access to breast cancer screenings). Lindsay has also advised on ongoing developmental operations
• Datix Holdco Limited on its acquisition of Verge Solutions, LLC
• Clearhaven Partners LLC in its acquisition of TimeTrade
• Gryphon Partners in its management of Heartland Veterinary Partners
• Waud Capital Partners in its management of Heart + Paw Holdings
• TA Associates in its management of Behavioral Health Works, Inc.
• Radiology Partners on its $885 million acquisition of MEDNAX Radiology Solutions
• TA Associates and Francisco Partners in their significant growth investment in Edifecs, Inc.
• Thomas H. Lee Partners on its acquisition of Seniorlink Inc.
• Charlesbank in its acquisition of Action Behavior Centers
• Cressey & Co. in its acquisition of HealthDrive
• Bansk Group in its purchase of Avrio
• Envision Healthcare Corp. and 216 of its affiliates in the commencement of pre-arranged Chapter 11 cases. Envision is a leading national medical group that employs or partners with more than 21,000 clinicians and provides care to patients across the U.S., with nearly 30 million patient visits each year. The two restructuring support agreements (on account of its two credit silos) contemplate, among other things, a collective deleveraging of approximately $7.4 billion of secured and unsecured debt and the separation of Envision’s physician services and ambulatory surgical center businesses
• Center for Autism and Related Disorders, LLC (“CARD”) and four of its affiliates in their Chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of Texas. CARD is one of the nation’s largest treatment providers for individuals diagnosed with autism spectrum disorder. Prior to filing for Chapter 11, CARD entered into a stalking horse asset purchase agreement for a going-concern sale of substantially all of CARD’s assets. CARD intends to use the Chapter 11 cases to run a competitive sale and bidding process to maximize enterprise value. CARD entered the Chapter 11 cases with a new money, delayed draw term loan debtor-in-possession financing facility from the company’s prepetition credit facility lenders

Epstein Becker & Green, P.C.

Winston & Strawn, LLP